Sipuleucel-T treatment prior to RP has been associated with intratumoral infiltration of CD3+, CD4+, FOXP3- and CD8+ T cells, IFNɣ-detectable responses and Th1-biased activation, which is important for host tumor immunity [70,71]. This evidence concerns the gene CD8A and neoplasm.